VEGFA and neoplasm: Because of FGF’s crucial involvement in glioblastoma tumor angiogenesis, treatments targeting FGF signaling pathways, such as FGFR inhibitors and combination therapies targeting FGF and other pro-angiogenic pathways such as VEGF, have been developed (Shah et al., 2008; Koch et al., 2012).